'New drugs soon for malaria, diabetes'
'The "candidate drugs" for malaria, osteoporosis and diabetes were currently undergoing clinical trials'. The Indian pharmaceutical sector would soon be showcasing ‘candidate drugs’ for malaria, osteoporosis
Central Drug Research Institute (CDRI)
-
Only 2% of drug samples are ‘not of standard quality’, says regulator
During nationwide surprise checks last year, Jammu region had the highest number of substandard drugs A special nationwide drive to check the quality of drugs by the national regulator for pharmaceuticals and medical devices has found that just a little over two per cent of the drug samples were not of standard quality. No spurious drugs were detected.
-
DGCI approving one drug a month without clinical trials: Panel report
In a scrutiny of 39 randomly picked drugs in India, a parliamentary panel found that in case of 11 drugs (28%), mandatory phase-III clinical trials were not conducted. Is the pill you're popping safe?
-
Workshop on IPRs at CDRI
LUCKNOW: Intellectual Property Rights (IPRs) play an important role in development of innovation driven sectors like drugs and pharmaceuticals. Despite recent spurt in promoting various aspects of IPRs during the last decade, the scientific community requires even more exposure to the complex issues involved.
-
Reetha effect
besides treating cold and constipation, the medicinal plant reetha is used as a contraceptive, called consap, for women. A study has now attributed another property to this contraceptive. Consap has been found effective against trichomoniasis, a protozoal disease that affects that genitourinary tract. Researchers at Central Drug Research Institute, Lucknow, who developed Consap from soap nut or
-
Vaccine gets clean bill of health
Report attributes death of infants to human error at Tiruvallur PHC THE measles vaccine administered to children in Tamil Nadu has been given a clean chit by the Central Drugs Laboratory at Kasauli in Himachal Pradesh. In its report submitted to the Union Health Ministry, the lab suggested that human error at the local level could have resulted in the death of four infants last month at Tiruvallur district. Samples of the vaccine had been sent to the lab following the death of children who had developed complications after receiving the vaccine shot.
-
Memory plus
The scientists of the Central Drug Research Institute of India (CDRI), Lucknow, conducted clinical tests on Memory Plus, a drug which owes its origin to the traditional herb